Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of vitamin C in the treatment of covid-19; and what steps his Department has taken to make use of vitamin C as part of covid-19 treatment.

The Department is continuing to monitor any new, high quality evidence from clinical trials in both the United Kingdom and overseas on the effectiveness of vitamin C as an intervention for COVID-19. One of the UK priority clinical trial platforms, REMAP-CAP, is trialling high-dose vitamin C in patients who have been admitted to an intensive care unit with COVID-19.

In parallel, the Department is working closely with RAPID C-19 as part of a multi-agency initiative to ensure any products deemed safe and effective in clinical trials to treat COVID-19 can rapidly be brought into wider use across the National Health Service.